384 related articles for article (PubMed ID: 34741815)
21. Clinical and Cost-effectiveness of a Comprehensive geriatric assessment and management for Canadian elders with Cancer-the 5C study: a study protocol for a randomised controlled phase III trial.
Puts MTE; Hsu T; Mariano C; Monette J; Brennenstuhl S; Pitters E; Ray J; Wan-Chow-Wah D; Kozlowski N; Krzyzanowska M; Amir E; Elser C; Jang R; Prica A; Krahn M; Beland F; Bergman S; Koneru R; Lemonde M; Szumacher E; Zidulka J; Fung S; Li A; Emmenegger U; Mehta R; Flemming K; Breunis H; Alibhai SMH
BMJ Open; 2019 May; 9(5):e024485. PubMed ID: 31079079
[TBL] [Abstract][Full Text] [Related]
22. Addition of a non-immersive virtual reality component to treadmill training to reduce fall risk in older adults (V-TIME): a randomised controlled trial.
Mirelman A; Rochester L; Maidan I; Del Din S; Alcock L; Nieuwhof F; Rikkert MO; Bloem BR; Pelosin E; Avanzino L; Abbruzzese G; Dockx K; Bekkers E; Giladi N; Nieuwboer A; Hausdorff JM
Lancet; 2016 Sep; 388(10050):1170-82. PubMed ID: 27524393
[TBL] [Abstract][Full Text] [Related]
23. Geriatric assessment-driven polypharmacy discussions between oncologists, older patients, and their caregivers.
Ramsdale E; Lemelman T; Loh KP; Flannery M; Kehoe L; Mullaney T; Wells M; Gilmore N; Plumb S; Mohile S
J Geriatr Oncol; 2018 Sep; 9(5):534-539. PubMed ID: 29530495
[TBL] [Abstract][Full Text] [Related]
24. Predicting chemotherapy toxicity in older adults: Comparing the predictive value of the CARG Toxicity Score with oncologists' estimates of toxicity based on clinical judgement.
Moth EB; Kiely BE; Stefanic N; Naganathan V; Martin A; Grimison P; Stockler MR; Beale P; Blinman P
J Geriatr Oncol; 2019 Mar; 10(2):202-209. PubMed ID: 30224184
[TBL] [Abstract][Full Text] [Related]
25. Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial.
Freyer DR; Chen L; Krailo MD; Knight K; Villaluna D; Bliss B; Pollock BH; Ramdas J; Lange B; Van Hoff D; VanSoelen ML; Wiernikowski J; Neuwelt EA; Sung L
Lancet Oncol; 2017 Jan; 18(1):63-74. PubMed ID: 27914822
[TBL] [Abstract][Full Text] [Related]
26. Using Geriatric Assessment to Guide Conversations Regarding Comorbidities Among Older Patients With Advanced Cancer.
Kleckner AS; Wells M; Kehoe LA; Gilmore NJ; Xu H; Magnuson A; Dunne RF; Jensen-Battaglia M; Mohamed MR; O'Rourke MA; Vogelzang NJ; Dib EG; Peppone LJ; Mohile SG
JCO Oncol Pract; 2022 Jan; 18(1):e9-e19. PubMed ID: 34228510
[TBL] [Abstract][Full Text] [Related]
27. Multicentre cluster randomised trial comparing a community group exercise programme and home-based exercise with usual care for people aged 65 years and over in primary care.
Iliffe S; Kendrick D; Morris R; Masud T; Gage H; Skelton D; Dinan S; Bowling A; Griffin M; Haworth D; Swanwick G; Carpenter H; Kumar A; Stevens Z; Gawler S; Barlow C; Cook J; Belcher C
Health Technol Assess; 2014 Aug; 18(49):vii-xxvii, 1-105. PubMed ID: 25098959
[TBL] [Abstract][Full Text] [Related]
28. Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial.
Kumar SK; Jacobus SJ; Cohen AD; Weiss M; Callander N; Singh AK; Parker TL; Menter A; Yang X; Parsons B; Kumar P; Kapoor P; Rosenberg A; Zonder JA; Faber E; Lonial S; Anderson KC; Richardson PG; Orlowski RZ; Wagner LI; Rajkumar SV
Lancet Oncol; 2020 Oct; 21(10):1317-1330. PubMed ID: 32866432
[TBL] [Abstract][Full Text] [Related]
29. Home Hazard Removal to Reduce Falls Among Community-Dwelling Older Adults: A Randomized Clinical Trial.
Stark S; Keglovits M; Somerville E; Hu YL; Barker A; Sykora D; Yan Y
JAMA Netw Open; 2021 Aug; 4(8):e2122044. PubMed ID: 34463746
[TBL] [Abstract][Full Text] [Related]
30. Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
Kang YK; Chen LT; Ryu MH; Oh DY; Oh SC; Chung HC; Lee KW; Omori T; Shitara K; Sakuramoto S; Chung IJ; Yamaguchi K; Kato K; Sym SJ; Kadowaki S; Tsuji K; Chen JS; Bai LY; Oh SY; Choda Y; Yasui H; Takeuchi K; Hirashima Y; Hagihara S; Boku N
Lancet Oncol; 2022 Feb; 23(2):234-247. PubMed ID: 35030335
[TBL] [Abstract][Full Text] [Related]
31. Fall prevention interventions in primary care to reduce fractures and falls in people aged 70 years and over: the PreFIT three-arm cluster RCT.
Bruce J; Hossain A; Lall R; Withers EJ; Finnegan S; Underwood M; Ji C; Bojke C; Longo R; Hulme C; Hennings S; Sheridan R; Westacott K; Ralhan S; Martin F; Davison J; Shaw F; Skelton DA; Treml J; Willett K; Lamb SE
Health Technol Assess; 2021 May; 25(34):1-114. PubMed ID: 34075875
[TBL] [Abstract][Full Text] [Related]
32. Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial.
Mir O; Cropet C; Toulmonde M; Cesne AL; Molimard M; Bompas E; Cassier P; Ray-Coquard I; Rios M; Adenis A; Italiano A; Bouché O; Chauzit E; Duffaud F; Bertucci F; Isambert N; Gautier J; Blay JY; Pérol D;
Lancet Oncol; 2016 May; 17(5):632-41. PubMed ID: 27068858
[TBL] [Abstract][Full Text] [Related]
33. Use of the Cancer and Aging Research Group Predictive Model for Chemotherapy-Related Toxic Effects in a Multiethnic, Older Adult Asian Population.
Pang A; Jiali L; Ng A; Cheng J; Wang M; Ng YS; Yao Y; Chun M; Ho F; Tey J
JAMA Netw Open; 2022 Oct; 5(10):e2237196. PubMed ID: 36255721
[TBL] [Abstract][Full Text] [Related]
34. Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial.
Winther SB; Liposits G; Skuladottir H; Hofsli E; Shah CH; Poulsen LØ; Ryg J; Osterlund P; Berglund Å; Qvortrup C; Glimelius B; Sorbye H; Pfeiffer P
Lancet Gastroenterol Hepatol; 2019 May; 4(5):376-388. PubMed ID: 30852136
[TBL] [Abstract][Full Text] [Related]
35. Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Baselga J; Im SA; Iwata H; Cortés J; De Laurentiis M; Jiang Z; Arteaga CL; Jonat W; Clemons M; Ito Y; Awada A; Chia S; Jagiełło-Gruszfeld A; Pistilli B; Tseng LM; Hurvitz S; Masuda N; Takahashi M; Vuylsteke P; Hachemi S; Dharan B; Di Tomaso E; Urban P; Massacesi C; Campone M
Lancet Oncol; 2017 Jul; 18(7):904-916. PubMed ID: 28576675
[TBL] [Abstract][Full Text] [Related]
36. Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial.
Diéras V; Miles D; Verma S; Pegram M; Welslau M; Baselga J; Krop IE; Blackwell K; Hoersch S; Xu J; Green M; Gianni L
Lancet Oncol; 2017 Jun; 18(6):732-742. PubMed ID: 28526536
[TBL] [Abstract][Full Text] [Related]
37. Family conferences and shared prioritisation to improve patient safety in the frail elderly (COFRAIL): study protocol of a cluster randomised intervention trial in primary care.
Mortsiefer A; Wilm S; Santos S; Löscher S; Wollny A; Drewelow E; Ritzke M; Thürmann P; Mann NK; Meyer G; Abraham J; Icks A; Montalbo J; Wiese B; Altiner A;
Trials; 2020 Mar; 21(1):285. PubMed ID: 32197631
[TBL] [Abstract][Full Text] [Related]
38. Clinical and cost-effectiveness of an intervention for reducing cholesterol and cardiovascular risk for people with severe mental illness in English primary care: a cluster randomised controlled trial.
Osborn D; Burton A; Hunter R; Marston L; Atkins L; Barnes T; Blackburn R; Craig T; Gilbert H; Heinkel S; Holt R; King M; Michie S; Morris R; Morris S; Nazareth I; Omar R; Petersen I; Peveler R; Pinfold V; Walters K
Lancet Psychiatry; 2018 Feb; 5(2):145-154. PubMed ID: 29396118
[TBL] [Abstract][Full Text] [Related]
39. Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial.
Hurvitz SA; Andre F; Jiang Z; Shao Z; Mano MS; Neciosup SP; Tseng LM; Zhang Q; Shen K; Liu D; Dreosti LM; Burris HA; Toi M; Buyse ME; Cabaribere D; Lindsay MA; Rao S; Pacaud LB; Taran T; Slamon D
Lancet Oncol; 2015 Jul; 16(7):816-29. PubMed ID: 26092818
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
